The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

The concentration-dependent decrease of intracellular D-Ser concentrations produced by incubation of PC-12 cells with the enantiomers of ketamine (Ket) and its major metabolites expressed as IC₅₀ values and percent (%) maximum decrease from vehicle-treated PC-12 cells. by Nagendra S. Singh (2620399)

KDM6A mRNA expression is decreased in PTFE mice. by Simon Lebek (9756148)

PRV-induced infertility is caused by decreased P4 level. by Bing-Qian Su (8616981)

Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

“…<p>Change in incidence (A) and diagnoses (B) if testing rates decrease by 30% and 50% relative to the current testing rate.…”

Compound 1 decreased the ΔΨm level of HepG-2 cells. by Jing Zhang (23775)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ_m decrease. by Martina Bielaszewska (79970)

“…<p>(<b>A, B</b>) HBMEC (<b>A</b>) and Caco-2 cells (<b>B</b>) were incubated for the times indicated with EHEC-Hly-containing OMVs TA50 or 8033 (20 µg of OMV protein containing 100 ng of EHEC-Hly) or with corresponding protein amounts of EHEC-Hly-negative OMVs TA51 or 8033c or left untreated (control). …”

a-f. PSP significantly decreased NP-specific IgM responses at days 4 and 21 compared to ACACIA. by Bhagwant Kaur Sekhon (847697)

Propofol induced cell death and decreased mitochondrial membrane potential in a concentration- and time-dependent manner. by Chisato Sumi (3521705)

WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [³H]-Thymidine incorporation assay. …”

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…CHPG, α-amino-2-chloro-5-hydroxybenzeneacetic acid; DHPG, (S)-3,5-Dihydroxyphenylglycine; GABA_A receptor, γ-Aminobutyric acid type A receptor; GDP-β-S, Guanosine 5ʹ-O-(2-Thiodiphosphate); GlyR, glycine receptor; IPSC, inhibitory postsynaptic current; mGluR5, metabotropic glutamate receptor 5; MPEP, 6-Methyl-2-(phenylethynyl) pyridine; PD98059, 2ʹ-Amino-3ʹ-methoxyflavone; Ro-32-0432, 2-{8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-3-yl}-3-(1-methyl-1H-indol-3-yl)maleimide.…”

Decrease of autoantibody levels in highly inflammatory NSG mice. by Henrika Jodeleit (4722312)

Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

“…Downregulation of <i>dom</i> decreased <i>per</i> and <i>tim</i> mRNA levels (middle and right panels), while <i>clk</i> was normal (left panel). …”

TMD residues decrease sensitivity. by Ákos Nemecz (356830)

“…Glu residues are color coded based upon effect, with residues in red producing a significant decrease in pH₅₀, and in yellow, an insignificant or weak effect, whereas the dark purple and magenta for His residues are synonymous to the red of Glu residues. …”

Silencing of Rap1A decreases ERK and p38 activation. by Yougen Wu (830191)

Decreased expression of HATL5 mRNA and protein in human carcinomas. by Gregory S. Miller (519005)

Chemical inhibition of formins decreases actin pedestal assembly by EPEC, but not by KC12+EspF_U. by Katrina B. Velle (4330957)

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)